# Verve Therapeutics

**Source:** https://www.startuphub.ai/startups/verve-therapeutics
**Profile type:** Startup

> Developing gene editing therapies to lower cholesterol.

## About

Verve Therapeutics is a biotechnology company focused on developing novel gene editing therapies to address cardiovascular disease. Their lead candidate, VERVE-102, is an experimental gene-editing therapy designed to permanently lower LDL cholesterol (bad cholesterol) after a single infusion. The therapy works by targeting PCSK9, a gene that plays a key role in regulating cholesterol levels. Early clinical trial results have shown promising safety and efficacy, with significant reductions in LDL cholesterol observed.

## Key facts

- **Slug:** verve-therapeutics
- **Website:** https://www.vervetx.com/
- **Location:** Cambridge, Massachusetts, USA
- **Founded:** 2018-01-01 00:00:00
- **Operating status:** Active
- **Total funding:** $300M
- **Sectors / tags:** Biotechnology, Gene Therapy, Cardiovascular Disease, Drug Delivery, Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, CRISPR
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/verve-therapeutics/
  - Twitter: https://twitter.com/VerveTx

## Frequently asked

### What does Verve Therapeutics do?

Verve Therapeutics is a biotechnology company focused on developing novel gene editing therapies to address cardiovascular disease. Their lead candidate, VERVE-102, is an experimental gene-editing therapy designed to permanently lower LDL cholesterol (bad cholesterol) after a single infusion. The therapy works by targeting PCSK9, a gene that plays a key role in regulating cholesterol levels. Early clinical trial results have shown promising safety and efficacy, with significant reductions in LDL…

### How much funding has Verve Therapeutics raised?

Verve Therapeutics has raised a total of $300M in funding. The most recent round on record is Series D.

### Where is Verve Therapeutics headquartered?

Verve Therapeutics is headquartered in Cambridge, Massachusetts, USA.

### When was Verve Therapeutics founded?

Verve Therapeutics was founded in 2018.

### What industry does Verve Therapeutics operate in?

Verve Therapeutics operates in Biotechnology, Gene Therapy, Cardiovascular Disease, Drug Delivery, Biotech, MedTech.

### What is Verve Therapeutics's revenue?

StartupHub estimates Verve Therapeutics's annual revenue at $65.9M (range $36.1M to $108.4M, 44% confidence), based on comparable companies in the sector.

### What is Verve Therapeutics's valuation?

StartupHub estimates Verve Therapeutics's effective valuation at $686.7M (range $480.7M to $892.7M, 28% confidence), based on comparable companies in the sector.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Verve Therapeutics",
          "item": "https://www.startuphub.ai/startups/verve-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/verve-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/verve-therapeutics",
      "name": "Verve Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Verve Therapeutics. Verve Therapeutics is a startup founded in 2018, operating in Biotechnology and Gene Therapy. Developing gene editing therapies to lower cholesterol. Headquartered in Cambridge, Massachusetts, USA.",
      "dateModified": "2026-07-07T14:52:50.374285+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/verve-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/verve-therapeutics#organization",
      "name": "Verve Therapeutics",
      "url": "https://www.vervetx.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/f6905aaf-2aeb-4592-948e-a4ffa03b9376-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/f6905aaf-2aeb-4592-948e-a4ffa03b9376-square.webp",
      "description": "This is the official profile of Verve Therapeutics. Verve Therapeutics is a startup founded in 2018, operating in Biotechnology and Gene Therapy. Developing gene editing therapies to lower cholesterol. Headquartered in Cambridge, Massachusetts, USA.",
      "sameAs": [
        "https://www.linkedin.com/company/verve-therapeutics/",
        "https://twitter.com/VerveTx",
        "https://www.startuphub.ai/startups/verve-therapeutics"
      ],
      "foundingDate": "2018-01-01 00:00:00",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressRegion": "Massachusetts",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Gene Therapy",
        "Cardiovascular Disease",
        "Drug Delivery",
        "Biotech",
        "MedTech",
        "HealthTech",
        "Drug Discovery",
        "Clinical Trials",
        "CRISPR"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/verve-therapeutics#profile-assessment",
      "name": "Verve Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/verve-therapeutics",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/f6905aaf-2aeb-4592-948e-a4ffa03b9376-square.webp",
      "category": "Biotechnology",
      "description": "This is the official profile of Verve Therapeutics. Verve Therapeutics is a startup founded in 2018, operating in Biotechnology and Gene Therapy. Developing gene editing therapies to lower cholesterol. Headquartered in Cambridge, Massachusetts, USA.",
      "brand": {
        "@type": "Brand",
        "name": "Verve Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-07",
        "name": "Verve Therapeutics - Profile Score 60/100",
        "reviewBody": "This is the official profile of Verve Therapeutics. Verve Therapeutics is a startup founded in 2018, operating in Biotechnology and Gene Therapy. Developing gene editing therapies to lower cholesterol. Headquartered in Cambridge, Massachusetts, USA.",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 60,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```